Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study
[ad_1] By Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The…
[ad_1] By Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The…
[ad_1] By Adria Calatayud Novartis said an interim analysis from a phase 3 trial to evaluate its investigational iptacopan drug in patients with kidney…
[ad_1] By David Sachs Roche said Friday that its Alecensa drug demonstrated the ability to reduce recurrence of lung cancer for patients in the…
[ad_1] By Colin Kellaher Shares of BioVie Inc. rose sharply in premarket trading Tuesday after the clinical-stage biopharmaceutical company reported positive results from a…
[ad_1] By Michael Susin GSK PLC said Monday that its Dreamm-3 Phase 3 study in patients with relapsed or refractory multiple myeloma didn’t meet…
[ad_1] Moderna stock shot up after Merck said it is exercising an option to work on a personalized cancer vaccine with the Covid-19 vaccine…
[ad_1] Press Release – updated: Apr 16, 2019 ANNAPOLIS, Md., April 16, 2019 (Newswire.com) – RealTerm Energy launches MyTown, a new smart city app…
[ad_1] The award-winning Chicago Comb Company has been granted one of the most distinguished awards for their products. They have been issued two design…